BREEDLOVE ROBERT CHARLES (Principal Accounting Officer) reported 1 transaction at PHATHOM PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/8/2026ACC: 0001193125-26-385250
Officer· Principal Accounting Officer
Since Feb 2026
-460.00
Net shares
Net seller
$4.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
460.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−460.00
Price / share
$9.05
Trade value
$4.16K
% of position
0.8%
9/3/2026
59.92K→59.47K
Total
Net shares
−460.00
Net value
-$4.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2026 | F · Tax Withholding | −460.00 | $9.05 | $4.16K | 0.8% | 59.92K | 59.47K |
| Total | −460.00 | -$4.16K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned8.19K
Total
8.19K indirect8.19K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.19K | Indirect |
| Total | 8.19K | 8.19K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported